Literature DB >> 27577878

Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.

Asbjørg Stray-Pedersen1, Hanne Sørmo Sorte2, Pubudu Samarakoon2, Tomasz Gambin3, Ivan K Chinn4, Zeynep H Coban Akdemir5, Hans Christian Erichsen6, Lisa R Forbes4, Shen Gu5, Bo Yuan7, Shalini N Jhangiani8, Donna M Muzny8, Olaug Kristin Rødningen9, Ying Sheng9, Sarah K Nicholas4, Lenora M Noroski10, Filiz O Seeborg10, Carla M Davis10, Debra L Canter10, Emily M Mace11, Timothy J Vece12, Carl E Allen13, Harshal A Abhyankar13, Philip M Boone7, Christine R Beck7, Wojciech Wiszniewski7, Børre Fevang14, Pål Aukrust14, Geir E Tjønnfjord15, Tobias Gedde-Dahl16, Henrik Hjorth-Hansen17, Ingunn Dybedal16, Ingvild Nordøy14, Silje F Jørgensen18, Tore G Abrahamsen19, Torstein Øverland6, Anne Grete Bechensteen6, Vegard Skogen20, Liv T N Osnes21, Mari Ann Kulseth9, Trine E Prescott9, Cecilie F Rustad9, Ketil R Heimdal9, John W Belmont22, Nicholas L Rider4, Javier Chinen10, Tram N Cao4, Eric A Smith23, Maria Soledad Caldirola24, Liliana Bezrodnik24, Saul Oswaldo Lugo Reyes25, Francisco J Espinosa Rosales25, Nina Denisse Guerrero-Cursaru26, Luis Alberto Pedroza26, Cecilia M Poli27, Jose L Franco28, Claudia M Trujillo Vargas28, Juan Carlos Aldave Becerra29, Nicola Wright30, Thomas B Issekutz31, Andrew C Issekutz31, Jordan Abbott32, Jason W Caldwell33, Diana K Bayer34, Alice Y Chan35, Alessandro Aiuti36, Caterina Cancrini37, Eva Holmberg38, Christina West39, Magnus Burstedt38, Ender Karaca5, Gözde Yesil40, Hasibe Artac41, Yavuz Bayram5, Mehmed Musa Atik5, Mohammad K Eldomery5, Mohammad S Ehlayel42, Stephen Jolles43, Berit Flatø44, Alison A Bertuch45, I Celine Hanson4, Victor W Zhang22, Lee-Jun Wong22, Jianhong Hu46, Magdalena Walkiewicz22, Yaping Yang22, Christine M Eng22, Eric Boerwinkle47, Richard A Gibbs8, William T Shearer10, Robert Lyle9, Jordan S Orange48, James R Lupski49.   

Abstract

BACKGROUND: Primary immunodeficiency diseases (PIDDs) are clinically and genetically heterogeneous disorders thus far associated with mutations in more than 300 genes. The clinical phenotypes derived from distinct genotypes can overlap. Genetic etiology can be a prognostic indicator of disease severity and can influence treatment decisions.
OBJECTIVE: We sought to investigate the ability of whole-exome screening methods to detect disease-causing variants in patients with PIDDs.
METHODS: Patients with PIDDs from 278 families from 22 countries were investigated by using whole-exome sequencing. Computational copy number variant (CNV) prediction pipelines and an exome-tiling chromosomal microarray were also applied to identify intragenic CNVs. Analytic approaches initially focused on 475 known or candidate PIDD genes but were nonexclusive and further tailored based on clinical data, family history, and immunophenotyping.
RESULTS: A likely molecular diagnosis was achieved in 110 (40%) unrelated probands. Clinical diagnosis was revised in about half (60/110) and management was directly altered in nearly a quarter (26/110) of families based on molecular findings. Twelve PIDD-causing CNVs were detected, including 7 smaller than 30 Kb that would not have been detected with conventional diagnostic CNV arrays.
CONCLUSION: This high-throughput genomic approach enabled detection of disease-related variants in unexpected genes; permitted detection of low-grade constitutional, somatic, and revertant mosaicism; and provided evidence of a mutational burden in mixed PIDD immunophenotypes.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Primary immunodeficiency disease; copy number variants; whole-exome sequencing

Mesh:

Year:  2016        PMID: 27577878      PMCID: PMC5222743          DOI: 10.1016/j.jaci.2016.05.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  86 in total

1.  Clan genomics and the complex architecture of human disease.

Authors:  James R Lupski; John W Belmont; Eric Boerwinkle; Richard A Gibbs
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 2.  Gene therapy for monogenic disorders of the bone marrow.

Authors:  Sujal Ghosh; Adrian J Thrasher; H Bobby Gaspar
Journal:  Br J Haematol       Date:  2015-06-05       Impact factor: 6.998

3.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

4.  Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers.

Authors:  H M Hoyeraal; J Lamvik; P J Moe
Journal:  Acta Paediatr Scand       Date:  1970-03

5.  Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay.

Authors:  Y K Huo; Z Wang; J H Hong; L Chessa; W H McBride; S L Perlman; R A Gatti
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

6.  CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduria.

Authors:  Carol Saunders; Laurie Smith; Flemming Wibrand; Kirstine Ravn; Peter Bross; Isabelle Thiffault; Mette Christensen; Andrea Atherton; Emily Farrow; Neil Miller; Stephen F Kingsmore; Elsebet Ostergaard
Journal:  Am J Hum Genet       Date:  2015-01-15       Impact factor: 11.025

7.  Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment.

Authors:  Yu Zhang; Xiaomin Yu; Mie Ichikawa; Jonathan J Lyons; Shrimati Datta; Ian T Lamborn; Huie Jing; Emily S Kim; Matthew Biancalana; Lynne A Wolfe; Thomas DiMaggio; Helen F Matthews; Sarah M Kranick; Kelly D Stone; Steven M Holland; Daniel S Reich; Jason D Hughes; Huseyin Mehmet; Joshua McElwee; Alexandra F Freeman; Hudson H Freeze; Helen C Su; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

8.  Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.

Authors:  Ender Karaca; Tamar Harel; Davut Pehlivan; Shalini N Jhangiani; Tomasz Gambin; Zeynep Coban Akdemir; Claudia Gonzaga-Jauregui; Serkan Erdin; Yavuz Bayram; Ian M Campbell; Jill V Hunter; Mehmed M Atik; Hilde Van Esch; Bo Yuan; Wojciech Wiszniewski; Sedat Isikay; Gozde Yesil; Ozge O Yuregir; Sevcan Tug Bozdogan; Huseyin Aslan; Hatip Aydin; Tulay Tos; Ayse Aksoy; Darryl C De Vivo; Preti Jain; B Bilge Geckinli; Ozlem Sezer; Davut Gul; Burak Durmaz; Ozgur Cogulu; Ferda Ozkinay; Vehap Topcu; Sukru Candan; Alper Han Cebi; Mevlit Ikbal; Elif Yilmaz Gulec; Alper Gezdirici; Erkan Koparir; Fatma Ekici; Salih Coskun; Salih Cicek; Kadri Karaer; Asuman Koparir; Mehmet Bugrahan Duz; Emre Kirat; Elif Fenercioglu; Hakan Ulucan; Mehmet Seven; Tulay Guran; Nursel Elcioglu; Mahmut Selman Yildirim; Dilek Aktas; Mehmet Alikaşifoğlu; Mehmet Ture; Tahsin Yakut; John D Overton; Adnan Yuksel; Mustafa Ozen; Donna M Muzny; David R Adams; Eric Boerwinkle; Wendy K Chung; Richard A Gibbs; James R Lupski
Journal:  Neuron       Date:  2015-11-04       Impact factor: 17.173

9.  Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.

Authors:  Andrea M Siegel; Kelly D Stone; Glenn Cruse; Monica G Lawrence; Ana Olivera; Mi-yeon Jung; John S Barber; Alexandra F Freeman; Steven M Holland; Michelle O'Brien; Nina Jones; Celeste G Nelson; Laura B Wisch; Heidi H Kong; Avanti Desai; Orly Farber; Alasdair M Gilfillan; Juan Rivera; Joshua D Milner
Journal:  J Allergy Clin Immunol       Date:  2013-11-01       Impact factor: 10.793

10.  Identification of copy number variants from exome sequence data.

Authors:  Pubudu Saneth Samarakoon; Hanne Sørmo Sorte; Bjørn Evert Kristiansen; Tove Skodje; Ying Sheng; Geir E Tjønnfjord; Barbro Stadheim; Asbjørg Stray-Pedersen; Olaug Kristin Rødningen; Robert Lyle
Journal:  BMC Genomics       Date:  2014-08-07       Impact factor: 3.969

View more
  94 in total

1.  Clinical challenges in the management of patients with B cell immunodeficiencies.

Authors:  J P Hodkinson; H Chapel
Journal:  Clin Exp Immunol       Date:  2017-06       Impact factor: 4.330

2.  Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency.

Authors:  Stella P Hartono; Alexander Vargas-Hernández; Mark J Ponsford; Ivan K Chinn; Stephen Jolles; Keith Wilson; Lisa R Forbes
Journal:  J Clin Immunol       Date:  2018-10-13       Impact factor: 8.317

3.  Fungal immunology in clinical practice: Magical realism or practical reality?

Authors:  Christina C Chang; Stuart M Levitz
Journal:  Med Mycol       Date:  2019-06-01       Impact factor: 4.076

4.  An overview of germline variations in genes of primary immunodeficiences through integrative analysis of ClinVar, HGMD® and dbSNP databases.

Authors:  Lyubov E Salnikova; Dmitry S Kolobkov; Darya A Sviridova; Serikbai K Abilev
Journal:  Hum Genet       Date:  2021-07-16       Impact factor: 4.132

5.  CNVxplorer: a web tool to assist clinical interpretation of CNVs in rare disease patients.

Authors:  Francisco Requena; Hamza Hadj Abdallah; Alejandro García; Patrick Nitschké; Sergi Romana; Valérie Malan; Antonio Rausell
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

6.  Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment.

Authors:  Raquel Ruiz-García; Alexander Vargas-Hernández; Ivan K Chinn; Laura S Angelo; Tram N Cao; Zeynep Coban-Akdemir; Shalini N Jhangiani; Qingchang Meng; Lisa R Forbes; Donna M Muzny; Luis M Allende; Mohammed S Ehlayel; Richard A Gibbs; James R Lupski; Gulbu Uzel; Jordan S Orange; Emily M Mace
Journal:  J Allergy Clin Immunol       Date:  2018-01-10       Impact factor: 10.793

7.  Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency.

Authors:  Hasibe Artac; Ayca Emsen; Hulya Ucaryilmaz; Halil Haldun Emiroglu; Vedat Uygun; Asbjørg Stray-Pedersen
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 8.  Use of Genetic Testing for Primary Immunodeficiency Patients.

Authors:  Jennifer R Heimall; David Hagin; Joud Hajjar; Sarah E Henrickson; Hillary S Hernandez-Trujillo; Yuval Tan; Lisa Kobrynski; Kenneth Paris; Troy R Torgerson; James W Verbsky; Richard L Wasserman; Elena W Y Hsieh; Jack J Blessing; Janet S Chou; Monica G Lawrence; Rebecca A Marsh; Sergio D Rosenzweig; Jordan S Orange; Roshini S Abraham
Journal:  J Clin Immunol       Date:  2018-04-19       Impact factor: 8.317

Review 9.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

10.  Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.

Authors:  Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.